By IDSE News Staff
A single oral dose of azithromycin has been shown to significantly reduce the risk for postpartum sepsis and death among women who deliver vaginally, according to the findings of the A-PLUS trial.
Between September 2020 and August 2022, researchers enrolled more than 29,000 women from seven low- and middle-income countries: Bangladesh, the Democratic Republic of the Congo, Guatemala, India, Kenya, Pakistan and Zambia (ClinicalTrials.gov Identifier: NCT03871491). The